Similar articles

• A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.

  Rutgers M, Gubbels AA, Hoefnagel CA, Voûte PA, Smets LA. Rutgers M, et al. Prog Clin Biol Res. 1991;366:471-8. Prog Clin Biol Res. 1991. PMID: 2068162 No abstract available.
• Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.

  O'Donoghue JA, Wheldon TE, Babich JW, Moyes JS, Barrett A, Meller ST. O'Donoghue JA, et al. Br J Radiol. 1991 May;64(761):428-34. doi: 10.1259/0007-1285-64-761-428. Br J Radiol. 1991. PMID: 2036567
• Iodine-125-MIBG therapy for neuroblastoma.

  Hoefnagel CA, Smets L, Voûte PA, de Kraku J. Hoefnagel CA, et al. J Nucl Med. 1991 Feb;32(2):361-2. J Nucl Med. 1991. PMID: 1992043 No abstract available.
• Radiolabelled mIBG in the treatment of neuroblastoma.

  Gaze MN, Wheldon TE. Gaze MN, et al. Eur J Cancer. 1996 Jan;32A(1):93-6. doi: 10.1016/0959-8049(95)00511-0. Eur J Cancer. 1996. PMID: 8695251 Review. No abstract available.
• Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.

  Smets LA, Rutgers M. Smets LA, et al. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):191-4. J Nucl Biol Med (1991). 1991. PMID: 1823816 Review. No abstract available.